PowerLoc MAX Power Injectable Infusion Set AllPoints Port Access System; Catalog Numbers AN132075...
FDA Device Recall #Z-2660-2020 — Class II — June 19, 2020
Recall Summary
| Recall Number | Z-2660-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 19, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton Dickinson & Company |
| Location | Franklin Lakes, NJ |
| Product Type | Devices |
| Quantity | 5,296,132 total |
Product Description
PowerLoc MAX Power Injectable Infusion Set AllPoints Port Access System; Catalog Numbers AN132075 (UDI 00801741118968), AN142010 (UDI 00801741119231), AN142010G (UDI 00801741119323), AN142075 (UDI 00801741119224)
Reason for Recall
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter occlusion, air embolism, under or interrupted infusion, or site contamination which could lead to infection.
Distribution Pattern
Worldwide Distribution
Lot / Code Information
Catalog Numbers AN132075 (UDI 00801741118968), AN142010 (UDI 00801741119231), AN142010G (UDI 00801741119323), AN142075 (UDI 00801741119224). Lot Numbers: REDT4257 REDV3617 REDY1815 REDY2789 REDZ0385 REEN2192 REEN2782 REDW2682 REDX1471 REDX3857 REDY0765 REDY1593 REDY2943 REDZ0676 REDZ1903 REDZ3077 REEN1222 REEN3292 REEP0666 REEP4137 REER0612 REDW1021 REDX1360 REDX4728 REDY1816 REDY2935 REDY3765 REDZ1825 REDZ3146 REEN1935 REEP0773 REEP3544 REEP4066 REER0579 REER1103 REDV2172 REDV3683 REDW0467 REDW0521 REDW1023 REDW1157 REDX1361 REDX1490 REDY0815 REDY1594 REDY2790 REDY3544 REDZ0110 REDZ0386 REDZ0677 REDZ1904 REDZ3078 REEN1072 REEN2186 REEN3075 REEN3310 REEP0663 REEP1401 REEP4138 REEQ0611 REEQ1246 REEQ2436 REEQ3589 REER0576 REER1046 REER2161 Additional lot added 10/16/20: REEU0314
Other Recalls from Becton Dickinson & Company
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1496-2026 | Class II | 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. ... | Jan 27, 2026 |
| Z-0504-2026 | Class II | BD Luer Tip Caps; Catalog Number(s) or Model N... | Oct 14, 2025 |
| Z-0736-2024 | Class II | PosiFlush Prefilled Saline Syringe with General... | Nov 16, 2023 |
| Z-0349-2024 | Class II | BD Alaris Pump infusion sets (Product Name, Cat... | Oct 11, 2023 |
| Z-0351-2024 | Class II | BD Extension Sets (Product Name, Catalog #) ... | Oct 11, 2023 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.